Lindy Harrell
Neurology · Birmingham, ALNPI 1164458139
Payments from drug & device makers
Across 61 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$304
- Indivior Inc.$95
- Novo Nordisk$87
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$78
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$65
- Novartis$56
- plus $395 from 15 others
What the payments were for
- Food & beverage$1,080100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $304 |
| Indivior Inc. | 4 | $95 |
| Novo Nordisk | 6 | $87 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Novartis | 2 | $56 |
| Boehringer Ingelheim | 3 | $44 |
| Amgen | 2 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| Astellas Pharma US Inc | 2 | $32 |
| Pear Therapeutics (US), Inc. | 1 | $27 |
| Alkermes, Inc. | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Ardelyx, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $13 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
How this compares
$1,080 in reported general payments places this provider in the 35th percentile of 255 neurology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 31 | $9,785 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $264 |
| Clonazepam | 12 | $38 |
Paid to pharmacies, not to this prescriber.
Other neurology in Birmingham
- Emily RiserBirmingham$7.1M
- Louis NaborsBirmingham$3.2M
- Khurram BashirBirmingham$2.8M
- David GeldmacherBirmingham$2.6M
- Victor SungBirmingham$2M
- Mina LobbousBirmingham$1.8M
- Diane CounceBirmingham$1.4M
- Marissa Natelson LoveBirmingham$792K
- David StandaertBirmingham$787K
- Marissa DeanBirmingham$592K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.